Antisense modulation of transcription factor DP-1 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsBrenda F. Baker, Susan M. Freier
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of transcription factor Dp-1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding transcription factor Dp-1. Methods of using these compounds for modulation of transcription factor Dp-1 expression and for treatment of diseases associated with expression of transcription factor Dp-1 are provided.
Claims20
A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding transcription factor Dp-1, wherein said compound specifically hybridizes with said nucleic acid molecule encoding transcription factor Dp-1 and inhibits the expression of transcription factor Dp-1.
A compound 8 to 80 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of a preferred target region on a nucleic acid molecule encoding transcription factor Dp-1.
Dependencies are inferred from the claim text.